Latest News

Filters

Filter by tags: United States Europe Rosatom Clear all tag filters

36 news articles found


The Nuclear Energy Agency (NEA) has published the second edition of its Small Modular Reactor Dashboard which tracks the progress of selected small modular reactor (SMR) designs towards deployment. NEA says the SMR designs are at various stages of development, from fundamental research on new concepts to commercial deployment and operation of mature designs.

Date: Saturday, 02 March 2024
Original article: neimagazine.com/news/newsnea-launches-second-edition-of-its-small-modular-reactor-dashboard-11561305

International Atomic Energy Agency (IAEA) Director General Rafael Mariano Grossi has said he hopes to "reinforce" the agency's team of experts at the Zaporizhzhia nuclear power plant to reflect its expanded role which includes monitoring compliance with the five safety and security principles outlined at the United Nations last week.

Date: Tuesday, 06 June 2023
Original article: world-nuclear-news.org/Articles/IAEA-preparing-to-expand-team-at-Zaporizhzhia

US-based NuScale Power has joined the Romanian Atomic Forum (Romatom) as a supporting member to champion the association’s nuclear energy goals. Romania aims to be the first country in Europe to deploy a NuScale VOYGR small modular reactor (SMR) power plant. John Hopkins, NuScale President & CEO, said NuScale was “committed to advancing the secure deployment of SMRs globally”.

Date: Friday, 26 May 2023
Original article: neimagazine.com/news/newsnuscale-power-joins-romanian-atomic-forum-10884712

In his latest update on the situation at the Zaporizhia NPP, IAEA  Director General Rafael Mariano Grossi said the plant had lost all external power for several hours, underlining the extremely precarious nuclear safety and security situation at the facility and the urgent need to protect it and prevent an accident.

Date: Wednesday, 24 May 2023
Original article: neimagazine.com/news/newszaporozhia-npp-loses-external-power-for-several-hours-10876375

The US has sensitive nuclear technology at a nuclear power plant inside Ukraine and is warning Russia not to touch it, according to a letter the US Department of Energy (DOE) sent to Rosatom, CNN reported. The letter, from the director of DOE’s Office of Nonproliferation Policy, Andrea Ferkile, was dated 17 March 2023. It tells Rosatom’s director general that the Zaporizhia nuclear power plant in Enerhodar “contains US-origin nuclear technical data that is export-controlled by the United States Government”.

Date: Saturday, 22 April 2023
Original article: neimagazine.com/news/newsus-warns-russia-not-to-touch-us-technology-at-zaporizhia-npp-10779550

Russia will switch the occupied Zaporizhzhia nuclear power plant back from US-made nuclear fuel as soon as possible, according to reported comments from Renat Karchaa, an adviser to Rosenergoatom's CEO. It follows a CNN report that the US Department of Energy had sent a letter saying that the occupied plant in Ukraine "contains US-origin nuclear technical data that is export-controlled by the United States Government".

Date: Friday, 21 April 2023
Original article: world-nuclear-news.org/Articles/Rosatom-ready-to-discuss-non-proliferation-and-exp

International Atomic Energy Agency (IAEA) Director General Rafael Mariano Grossi says that the Zaporizhzhia nuclear power plant's reliance on a single functioning external power line, and two landmine explosions near the plant, mean it is "more important than ever to agree" safety measures for the site. 

Date: Saturday, 15 April 2023
Original article: world-nuclear-news.org/Articles/Landmine-explosions-underline-need-for-Zaporizhzhi

Advances in emerging field of ‘theranostics’ are a game-changer Millions of patients around the globe rely on the regular and timely production of diagnostic and therapeutic isotopes produced in research reactors and accelerator facilities. Image courtesy IAEA. Advances in medical isotope diagnostics and therapy are holding promise for cancer patients, despite challenges facing the nuclear medical field in recent years related to radionuclide production and supply, rising costs, and stricter regulation.

Medical isotopes are radioactive substances used in various diagnostic and therapeutic procedures to treat various types of cancers and other conditions. They are essential for modern medicine, allowing physicians to visualise and target specific organs, tissues and cells in a patient’s body.

Over more than a decade, personalised medicine using nuclear techniques has been gaining pace, allowing doctors to tailor therapies and treatments to the specific needs and physiology of a patient, and to avoid harm to healthy organs or tissues.

According to Sven Van den Berghe, chief executive of Belgium-based isotope producer PanTera, one technique that has seen significant advances is known as theranostics – the term used to describe the combination of using one radioactive drug to diagnose and a second to deliver therapy to treat the main tumour and any metastatic tumours.

Date: Friday, 14 April 2023
Original article: nucnet.org/news/sector-aims-to-tackle-isotope-supply-problems-as-excitement-grows-over-targeted-therapies-4-4-2023